Signed up an exclusive license and supply agreement in China with Deva Holding A.Ş. for one product that has been approved and launchedin Europe

Signed upan exclusive license and supply agreement in China with Cipla for two FDA-approved products, includingEsomeprazole Magnesium for Delayed-Release Oral Suspension which is the first FDA-approved ANDA

Signed upan exclusive license and supply agreement with EMP Pharma for an innovative oral solution in China

Beimei R&D Center forPediatric Medicines officially put into use

Signed up license and supply agreements with Hetero on four FDA-approved prescription drugs for children, including Oseltamivir Phosphate for Suspension

An angel round of investment individually by Mr Wang Jiannan with the amount of 10 million RMB

February: Signedup a license and supply agreement with Workhardton oneFDA-approved prescription drugfor children

Establishedan employee shareholding platform accounting for 15% of Beimei Pharma

Invested in self-developedprojectBMR03TM,in cooperation with Guangzhou RenhengPharm